LON:CNSL Cambridge Nutritional Sciences (CNSL) Share Price, News & Analysis GBX 1.30 -0.10 (-7.14%) As of 09/11/2026 12:15 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsInsider Trades About Cambridge Nutritional Sciences Stock (LON:CNSL) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get CNSL alerts:Sign Up Key Stats Today's Range 1.30▼ 1.5050-Day Range 1.30▼ 2.1052-Week Range 1.26▼ 3.30Volume93,629 shsAverage Volume219,738 shsMarket Capitalization£3.09 millionP/E Ratio2.17Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition. Read More Receive CNSL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cambridge Nutritional Sciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CNSL Stock News HeadlinesCambridge Nutritional Sciences Reschedules AGM and Publishes 2026 Annual ReportSeptember 11 at 9:31 AM | tipranks.comCambridge Nutritional Sciences Publishes Annual Report and Sets September AGMSeptember 8, 2026 | tipranks.comBezos… DOOMEDA single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X combined - aimed at the $25 trillion AI industry. James Altucher says the plan could cut Amazon out of the AI race and disrupt Blue Origin, with a key deadline landing September 25.September 12 at 1:00 AM | Paradigm Press (Ad)Cambridge Nutritional Sciences Sets Date for 2026 Results and Investor PresentationAugust 3, 2026 | tipranks.comCambridge Nutritional Sciences Leadership Increases ShareholdingsNovember 19, 2025 | tipranks.comCambridge Nutritional Sciences Faces Historical Legal ChallengeJanuary 21, 2025 | tipranks.comCambridge Nutritional Sciences Resolves Legal Dispute with DHSCJanuary 16, 2025 | tipranks.comSee More Headlines CNSL Stock Analysis - Frequently Asked Questions How have CNSL shares performed this year? Cambridge Nutritional Sciences' stock was trading at GBX 1.94 at the beginning of the year. Since then, CNSL stock has decreased by 33.1% and is now trading at GBX 1.30. How were Cambridge Nutritional Sciences' earnings last quarter? Cambridge Nutritional Sciences plc (LON:CNSL) announced its quarterly earnings data on Tuesday, September, 8th. The company reported ($2.40) EPS for the quarter. Cambridge Nutritional Sciences had a negative trailing twelve-month return on equity of 69.62% and a negative net margin of 83.53%. How do I buy shares of Cambridge Nutritional Sciences? Shares of CNSL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Company Calendar Last Earnings9/08/2026Today9/12/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryN/A Current SymbolLON:CNSL CIKN/A Webwww.cnsplc.com Phone(217) 235-3311FaxN/AEmployees3,200Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX 0.60 Trailing P/E Ratio2.17 Forward P/E Ratio35.26 P/E GrowthN/ANet Income-£3.03 million Net Margins-83.53% Pretax MarginN/A Return on Equity-69.62% Return on Assets-2.36% Debt Debt-to-Equity Ratio2.20 Current Ratio3.40 Quick RatioN/A Sales & Book Value Annual Sales£8.06 million Price / Sales0.38 Cash FlowN/A Price / Cash FlowN/A Book ValueGBX 4 per share Price / Book0.33Miscellaneous Outstanding Shares237,951,000Free FloatN/AMarket Cap£3.09 million OptionableN/A Beta1.91 The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (LON:CNSL) was last updated on 9/12/2026 by MarketBeat.com Staff. From Our PartnersThis 38 Dollar Fund Holds Every Major AI Stock and Pays WeeklyThe biggest AI stocks like Nvidia, CrowdStrike, and Palantir now trade for hundreds of dollars a share. One fu...Investors Alley | SponsoredThe retirement stock I'd buy before Nvidia todayIn 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...Chaikin Analytics | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredThe retirement income that answers “yes” when everything else says noTodd Phillips has spent 30 years studying safe-money income. He says most so-called income sources fail one te...Eagle Publishing | Sponsored17 Nobel Prize winners… one startling warningOn July 13, 17 Nobel laureates including Bernanke, Krugman, and Stiglitz signed an 88-word letter warning that...Porter & Company | SponsoredI called NVDA at $6 - Here's what’s next…Matt McCall called NVDA at 6 dollars - it's since climbed more than 3,100 percent. He's identified 51 stocks t...Monument Traders Alliance | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cambridge Nutritional Sciences plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Cambridge Nutritional Sciences With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.